Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA; Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
JACC Cardiovasc Interv. 2024 Aug 12;17(15):1811-1821. doi: 10.1016/j.jcin.2024.04.039. Epub 2024 Jul 3.
With an aging population and an increase in the comorbidity burden of patients undergoing percutaneous coronary intervention (PCI), the management of coronary calcification for optimal PCI is critical in contemporary practice.
This study sought to examine the trends and outcomes of coronary intravascular lithotripsy (IVL), rotational/orbital atherectomy, or both among patients who underwent PCI in Michigan.
We included all PCIs between January 1, 2021, and June 30, 2022, performed at 48 Michigan hospitals. Outcomes included in-hospital major adverse cardiac events (MACEs) and procedural success.
IVL was used in 1,090 patients (2.57%), atherectomy was used in 1,743 (4.10%) patients, and both were used in 240 patients (0.57% of all PCIs). IVL use increased from 0.04% of PCI cases in January 2021 to 4.28% of cases in June 2022, ultimately exceeding the rate of atherectomy use. The rate of MACEs (4.3% vs 5.4%; P = 0.23) and procedural success (89.4% vs 89.1%; P = 0.88) were similar among patients treated with IVL compared with atherectomy, respectively. Only 15.6% of patients treated with IVL in contemporary practice were similar to the population enrolled in the pivotal IVL trials. Among such patients (n = 169), the rate of MACEs (0.0%) and procedural success (94.7%) were similar to the outcomes reported in the pivotal IVL trials.
Since its introduction in February 2021, coronary IVL use has steadily increased, exceeding atherectomy use in Michigan by February 2022. Contemporary use of IVL and atherectomy is generally associated with high rates of procedural success and low rates of complications.
随着人口老龄化和接受经皮冠状动脉介入治疗(PCI)的患者合并症负担的增加,优化 PCI 时的冠状动脉钙化管理在当代实践中至关重要。
本研究旨在检查密歇根州接受 PCI 治疗的患者中冠状动脉腔内碎石术(IVL)、旋磨/旋切术或两者联合应用的趋势和结果。
我们纳入了 2021 年 1 月 1 日至 2022 年 6 月 30 日在密歇根州 48 家医院进行的所有 PCI。结果包括院内主要不良心脏事件(MACE)和手术成功率。
1090 例患者(2.57%)使用了 IVL,1743 例患者(4.10%)使用了旋磨/旋切术,240 例患者(0.57%的所有 PCI)同时使用了这两种方法。IVL 的使用率从 2021 年 1 月的 0.04%增加到 2022 年 6 月的 4.28%,最终超过了旋磨/旋切术的使用率。与旋磨/旋切术相比,接受 IVL 治疗的患者的 MACE 发生率(4.3%比 5.4%;P=0.23)和手术成功率(89.4%比 89.1%;P=0.88)相似。在当代实践中,仅 15.6%接受 IVL 治疗的患者与关键 IVL 试验入组人群相似。在这些患者中(n=169),MACE 发生率(0.0%)和手术成功率(94.7%)与关键 IVL 试验报告的结果相似。
自 2021 年 2 月推出以来,冠状动脉 IVL 的使用稳步增加,到 2022 年 2 月在密歇根州已超过旋磨/旋切术的使用。当代 IVL 和旋磨/旋切术的应用通常与较高的手术成功率和较低的并发症发生率相关。